Correlation Between Lyra Therapeutics and Orgenesis

Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Orgenesis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Orgenesis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lyra Therapeutics and Orgenesis, you can compare the effects of market volatilities on Lyra Therapeutics and Orgenesis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Orgenesis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Orgenesis.

Diversification Opportunities for Lyra Therapeutics and Orgenesis

0.0

Correlation Coefficient

Lyra Therapeutics  Orgenesis

Pay attention - limited upside

The 3 months correlation between Lyra and Orgenesis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Orgenesis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orgenesis and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Orgenesis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orgenesis has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Orgenesis go up and down completely randomly.

Pair Corralation between Lyra Therapeutics and Orgenesis

If you would invest  520.00  in Lyra Therapeutics on May 5, 2025 and sell it today you would earn a total of  138.00  from holding Lyra Therapeutics or generate 26.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Lyra Therapeutics  vs.  Orgenesis

Lyra Therapeutics

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Lyra Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Lyra Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Orgenesis

Risk-Adjusted Performance

Very Weak

Over the last 90 days Orgenesis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Orgenesis is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Lyra Therapeutics and Orgenesis

The main advantage of trading using opposite Lyra Therapeutics and Orgenesis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Orgenesis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will offset losses from the drop in Orgenesis' long position.

The idea behind Lyra Therapeutics and Orgenesis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.